Business Description
D. Western Therapeutics Institute Inc
ISIN : JP3548740004
Description
D. Western Therapeutics Institute Inc is engaged in the research and development of pharmaceutical drugs in Japan. Its products include ophthalmic solution and agents for antiplatelet and anti-glaucoma.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.17 | |||||
| Equity-to-Asset | 0.41 | |||||
| Debt-to-Equity | 1.3 | |||||
| Debt-to-EBITDA | -1.02 | |||||
| Piotroski F-Score | 1/9 | |||||
| Altman Z-Score | 0.57 | |||||
| Beneish M-Score | -3.3 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 1 | |||||
| 3-Year EBITDA Growth Rate | -40.2 | |||||
| 3-Year EPS without NRI Growth Rate | -34.7 | |||||
| 3-Year FCF Growth Rate | -32.5 | |||||
| 3-Year Book Growth Rate | -18.6 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 35.9 | |||||
| 9-Day RSI | 50.22 | |||||
| 14-Day RSI | 55.53 | |||||
| 6-1 Month Momentum % | 6.73 | |||||
| 12-1 Month Momentum % | -39.75 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 19.32 | |||||
| Quick Ratio | 18.24 | |||||
| Cash Ratio | 13.6 | |||||
| Days Inventory | 906.47 | |||||
| Days Sales Outstanding | 104.74 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -3.2 | |||||
| Shareholder Yield % | -0.18 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 91.27 | |||||
| Operating Margin % | -213.29 | |||||
| Net Margin % | -233.77 | |||||
| FCF Margin % | -133.47 | |||||
| ROE % | -82.77 | |||||
| ROA % | -45.2 | |||||
| ROIC % | -192.64 | |||||
| ROC (Joel Greenblatt) % | -409.15 | |||||
| ROCE % | -48.63 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 11.37 | |||||
| PB Ratio | 6.32 | |||||
| Price-to-Tangible-Book | 6.84 | |||||
| EV-to-EBIT | -5.51 | |||||
| EV-to-EBITDA | -5.51 | |||||
| EV-to-Revenue | 12.92 | |||||
| EV-to-FCF | -9.97 | |||||
| Price-to-Median-PS-Value | 0.39 | |||||
| Price-to-Net-Current-Asset-Value | 8.47 | |||||
| Price-to-Net-Cash | 59.06 | |||||
| Earnings Yield (Greenblatt) % | -18.15 | |||||
| FCF Yield % | -9.72 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
D. Western Therapeutics Institute Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 2.871 | ||
| EPS (TTM) (€) | -0.209 | ||
| Beta | 0.82 | ||
| Volatility % | 77.35 | ||
| 14-Day RSI | 55.53 | ||
| 14-Day ATR (€) | 0.076237 | ||
| 20-Day SMA (€) | 0.8001 | ||
| 12-1 Month Momentum % | -39.75 | ||
| 52-Week Range (€) | 0.266 - 1.37 | ||
| Shares Outstanding (Mil) | 37.98 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
D. Western Therapeutics Institute Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
D. Western Therapeutics Institute Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
D. Western Therapeutics Institute Inc Frequently Asked Questions
What is D. Western Therapeutics Institute Inc(FRA:6DW)'s stock price today?
The current price of FRA:6DW is €0.90. The 52 week high of FRA:6DW is €1.37 and 52 week low is €0.27.
When is next earnings date of D. Western Therapeutics Institute Inc(FRA:6DW)?
The next earnings date of D. Western Therapeutics Institute Inc(FRA:6DW) is .
Does D. Western Therapeutics Institute Inc(FRA:6DW) pay dividends? If so, how much?
D. Western Therapeutics Institute Inc(FRA:6DW) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers